Is a complete NSE/MEDICAMEQ research report available?

No complete published report is available for nse/MEDICAMEQ (NSE/MEDICAMEQ) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/MEDICAMEQ stock profile: metrics, valuation and analysis

Market cap	3.6B
Revenue (ttm)	2.1B
Net income (ttm)	96.1M
EPS (ttm)	₹7.45
P/E (trailing)	37.8x
Dividend	₹1.00 (0.38%)
Volume	60,359
Beta	0.72

All NSE/MEDICAMEQ indicators

Market & fundamental data

Available fields

194

Groups with data

Currency

INR

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	376
Employees Change	-2%
Employees Change Percent	-0.53
Enterprise value	INR 3.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.65
Industry PE Fwd	33.99
Isin	INE646B01010
Last refreshed	2026-09-09
Market cap	INR 3.6B
Price	INR 286
Price currency	INR
Rev Per Employee	5,482,085.11x
Sector	Healthcare
Sector PE	47.97
Sector PE Fwd	38.43
Sic	2834
Symbol	nse/MEDICAMEQ
Website	https://www.medicamen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.65%
EV Earnings	39.51x
EV/EBIT	24.34x
EV/EBITDA	16.58x
EV/Sales	1.84x
FCF yield	-10.45%
P/B ratio	1.32x
P/E ratio	37.79x
P/S ratio	1.76x
PE Ratio10 Y	57.86x
PE Ratio3 Y	61.55x
PE Ratio5 Y	62.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.57%
EBITDA Margin	11.11%
Gross margin	51.4%
Gross Profit	INR 1.1B
Gross Profit Growth	24.01%
Gross Profit Growth Q	32.86%
Gross Profit Growth3 Y	12.88%
Gross Profit Growth5 Y	16.63%
Net Income	INR 96.1M
Net Income Growth	21.45%
Net Income Growth Q	-1.61%
Net Income Growth Qo Q	-45.08%
Net Income Growth Years	1%
Net Income Growth3 Y	-14.62%
Net Income Growth5 Y	-7.3%
Pretax Margin	6.03%
Profit Margin	4.66%
Profit Per Employee	INR 255,497
Profitable Quarters	INR 42
Profitable Years	13
Roa5y	3.68
Roe5y	6.24
ROIC	4.32
Roic5y	6.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.08%
Cagr3y	-26.24%
Div CAGR3	0%
EPS Growth	12.21
EPS Growth Q	15.25
EPS Growth Qo Q	-58.54
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	-14.71
EPS Growth5 Y	-8.3
Revenue Growth	22.21x
Revenue Growth Q	12.05x
Revenue Growth Qo Q	-21.84x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	11.25x
Revenue Growth5 Y	12.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 312.6M
Debt	INR 477.8M
Debt EBITDA	INR 2.09
Debt Equity	INR 0.17
Debt FCF	INR -1.26
Equity	INR 2.8B
Interest Coverage	4.92
Net Cash	INR -165.2M
Net Cash By Market Cap	INR -4.55
Net Debt EBITDA	INR 0.72
Net Debt Equity	INR 0.06
Tangible Book Value	INR 2.7B
Tangible Book Value Per Share	INR 234
WACC	7.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.24%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 1
Dividend Years	6
Dividend Yield	0.38%
Ex Div Date	2026-09-18
Last Dividend	INR 1
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20.07%
200-day SMA	294.4
3Y total return	-59.88%
50-day SMA	244.3
50-day SMA vs 200-day SMA	50under200
All Time High	1,225
All Time High Change	-77.2%
All Time High Date	2022-09-01
All Time Low	212.4
All Time Low Change	31.47%
All Time Low Date	2026-06-29
ATR	14.35
Beta	0.72
Ch YTD	-23.42
High	287.8
High52	447.7
High52 Date	2025-11-25
High52ch	-36.17%
Low	275
Low52	212.4
Low52 Date	2026-06-29
Low52ch	34.53%
Ma50ch	14.29%
Price vs 200-day SMA	-5.16%
RSI	66.61
RSI Monthly	41.92
RSI Weekly	52.82
Sharpe ratio	-0.32x
Sharpe Ratio3y	-0.49x
Sortino ratio	-0.35
Sortino Ratio3y	-0.65
Total Return	-7.86%
Tr YTD	-23.42
Tr1m	17.5%
Tr1w	6.8%
Tr3m	13.68%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,845,546%
Net Borrowing	145,306,000
Shares Insiders	7.15%
Shares Institutions	0.69%
Shares Qo Q	32.46%
Shares Yo Y	8.24%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	50,774.25x
Bv Per Share	234.3
CAPEX	INR -47.8M
Ch1m	17.5
Ch1w	6.8
Ch1y	-20.31
Ch3m	13.68
Ch3y	-60.14
Ch6m	-4.1
Change	2.33%
Change From Open	1.33
Close	279.3
Days Gap	0.98
Depreciation Amortization	72,956,000
Dollar Volume	17,247,584.3
Earnings Date	2026-08-14
EBIT	INR 156M
EBITDA	INR 228.9M
EPS	INR 7.45
F Score	2
FCF	INR -379.5M
FCF EV Yield	-10x
Financing CF	637,158,000
Fiscal Year End	March
Founded	1,993
Graham Number	192.07903
Graham Upside	-32.78
Income Tax	INR 23.8M
Investing CF	-30,387,000
Is Primary Listing	0
Last Earnings Date	2026-08-14
Last Report Date	2026-06-30
Lynch Fair Value	INR 37.8
Lynch Upside	-86.77
Ma150	264.5
Ma150ch	5.57%
Ma20	245.7
Ma20ch	13.64%
Net CF	275,048,000
Next Earnings Date	2026-11-12
Open	282
Payment Date	2026-10-26
Position In Range	83.98
Price Date	2026-09-08
Price EBITDA	INR 15.86
Ptbv Ratio	1.32
Relative Volume	1.19x
Revenue	2,061,264,000x
Tax By Revenue	1.16x
Tax Rate	19.18%
Tr6m	-4.1%
Volume	60,359

NSE/MEDICAMEQ (NSE/MEDICAMEQ)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/MEDICAMEQ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/MEDICAMEQ indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/MEDICAMEQ

Frequently asked questions